Sentiment-Signal
Score-Verlauf (90 Tage)
Stammdaten
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Unternehmen & Branche
| Name | Progyny, Inc. |
|---|---|
| Ticker | PGNY |
| CIK | 0001551306 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Healthcare Information Services |
| SIC | 8090 · Services-Misc Health & Allied Services, NEC |
Wertpapier & Kennzahlen
| CUSIP | 74340e103 |
|---|---|
| ISIN | US74340E1038 |
| Typ | Common Stock |
| Marktkapitalisierung | 1,51 Mrd. USD |
| Beta | 0,99 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 1,288,661,000 | 58,520,000 | 0.65 | 742,435,000 | 516,044,000 |
| 2025-09-30 | 10-K | 313,346,000 | 13,864,000 | 0.15 | ||
| 2025-09-30 | 10-Q | 313,346,000 | 13,864,000 | 0.15 | 795,227,000 | 560,004,000 |
| 2025-06-30 | 10-Q | 332,874,000 | 17,112,000 | 0.19 | 760,950,000 | 515,022,000 |
| 2025-06-30 | 10-K | 332,874,000 | 17,112,000 | 0.19 | ||
| 2025-03-31 | 10-Q | 324,038,000 | 15,059,000 | 0.17 | 730,285,000 | 467,159,000 |
| 2025-03-31 | 10-K | 324,038,000 | 15,059,000 | 0.17 | ||
| 2024-12-31 | 10-K | 298,431,000 | 10,532,000 | 0.12 | 607,102,000 | 422,062,000 |
| 2024-09-30 | 10-Q | 286,625,000 | 10,421,000 | 0.11 | 659,972,000 | 434,876,000 |
| 2024-09-30 | 10-K | 286,625,000 | 10,421,000 | 0.11 | ||
| 2024-06-30 | 10-Q | 304,087,000 | 16,485,000 | 0.17 | 698,632,000 | 456,193,000 |
| 2024-06-30 | 10-K | 304,087,000 | 16,485,000 | 0.17 | ||
| 2024-03-31 | 10-K | 278,078,000 | 16,898,000 | 0.17 | ||
| 2024-03-31 | 10-Q | 278,078,000 | 16,898,000 | 0.17 | 794,304,000 | 571,604,000 |
| 2023-12-31 | 10-K | 269,940,000 | 13,470,000 | 0.13 | 756,620,000 | 553,429,000 |
| 2023-09-30 | 10-Q | 15,898,000 | 0.16 | 726,512,000 | 515,393,000 | |
| 2023-09-30 | 10-K | 280,891,000 | 15,898,000 | 0.16 | ||
| 2023-06-30 | 10-K | 279,373,000 | 14,991,000 | 0.15 | ||
| 2023-06-30 | 10-Q | 14,991,000 | 0.15 | 681,537,000 | 469,499,000 | |
| 2023-03-31 | 10-K | 258,394,000 | 17,678,000 | 0.18 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-04 | Swartz Allison | Officer, EVP, GC | Open Market Sale | -599 | 17.54 | -10,506.46 | -5,1% | |
| 2026-03-03 | Swartz Allison | Officer, EVP, GC | Open Market Sale | -4,157 | 17.40 | -72,331.80 | -35,1% | |
| 2026-03-03 | Swartz Allison | Officer, EVP, GC | Open Market Sale | -500 | 17.40 | -8,698.00 | -4,2% | |
| 2026-03-02 | Swartz Allison | Officer, EVP, GC | Open Market Sale | -2,199 | 17.27 | -37,976.73 | -18,5% | |
| 2025-12-11 | Livingston Mark S. | Officer, CHIEF FINANCIAL OFFICER | Open Market Sale | -459 | 25.50 | -11,704.50 | -5,7% | |
| 2025-12-04 | Swartz Allison | Officer, EVP, GC | Open Market Sale | -530 | 24.59 | -13,032.70 | -6,3% | |
| 2025-12-02 | Livingston Mark S. | Officer, CHIEF FINANCIAL OFFICER | Open Market Sale | -213 | 25.50 | -5,431.50 | -2,6% | |
| 2025-11-28 | Swartz Allison | Officer, EVP, GC | Open Market Sale | -2,398 | 26.87 | -64,434.26 | -31,3% | |
| 2025-11-17 | Livingston Mark S. | Officer, CHIEF FINANCIAL OFFICER | Open Market Sale | -21,303 | 25.50 | -543,226.50 | -263,9% | |
| 2025-11-13 | Anevski Peter | Director, Officer, CHIEF EXECUTIVE OFFICER | Open Market Purchase | 79,500 | 24.29 | 1,930,896.00 | +938,1% | |
| 2025-09-04 | Swartz Allison | Officer, EVP, GC | Open Market Sale | -599 | 23.53 | -14,094.47 | -6,8% | |
| 2025-08-28 | Swartz Allison | Officer, EVP, GC | Open Market Sale | -2,398 | 22.96 | -55,058.08 | -26,8% | |
| 2025-08-11 | GORDON KEVIN K | Director | Open Market Sale | -2,500 | 22.04 | -55,087.50 | -26,8% | |
| 2025-06-11 | Scott Cheryl | Director | Open Market Sale | -2,675 | 22.07 | -59,037.25 | -28,7% |
Top-Fondshalter
Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.03.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| SVB WEALTH LLC | 154 | 3,440 | 100.00 |